Table 1.
LCH | HCH | |
---|---|---|
Subjects (n) | 37 | 38 |
Female/male | 18/19 | 21/17 |
DM (n; %) | 9; 24 | 8; 21 |
Cause of catheter insertion: incident/prevalent renal failure | 10/27 | 12/26 |
Age (years) | 64 ± 15 | 65 ± 14 |
ASA (n; %) | 10; 28 | 9; 26 |
LMWH (n; %) | 3; 8 | 3; 8 |
HGB (g/dl) | 10.2 ± 1.9 | 10.3 ± 1.8 |
PLT (×103/µl) | 215.1 ± 67.5 | 215.3 ± 99.4 |
FBG (mg/dl) | 431.7 ± 200.7 | 424.7 ± 203.4 |
APTT (s) | 38.8 ± 5.9 | 38.9 ± 5.3 |
INR | 1.09 ± 0.11 | 1.08 ± 0.11 |
APTT activated partial thromboplastin time, ASA use of acetylsalicylic acid, FBG fibrinogen, HCH high concentration of heparin, HGB hemoglobin, INR international normalized ratio, LCH low concentration of heparin, LMWH use of low molecular weight heparin, PLT platelet count